Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,200 across all filing types
Latest filing 2023-05-03 Capital/Financing Update
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Press Release
Capital/Financing Update Classification · 90% confidence The document is a press release dated May 3, 2023, announcing a strategic partnership between Strides Pharma Science Limited and Orbicular Pharmaceutical Technologies Private Limited to jointly develop nasal sprays. It contains no financial statements, regulatory filings, or detailed financial data. It is a corporate announcement about a business partnership and product development collaboration. The document is not an annual report, earnings release, management report, or any other detailed financial or regulatory filing. It is a press release about a strategic partnership, which fits best under the category of Capital/Financing Update (CAP) as it relates to business development and strategic partnership announcements that impact company operations and potential capital deployment. The document length is 5078 characters, which is sufficient for a press release but not a full report. Therefore, the most appropriate classification is CAP with high confidence.
2023-05-03 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2023-04-27 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding compliance under SEBI regulations about the issuance of duplicate share certificates to a shareholder. It includes details of old and new certificate numbers and proof of dispatch. There is no financial data, no report attached or referenced, and the document is short (1679 characters). It is an official regulatory communication about share certificate issuance and compliance, not a financial report or announcement of voting results or capital changes. Therefore, it fits best under Regulatory Filings (RNS) as a compliance-related announcement under SEBI regulations.
2023-04-24 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding compliance under SEBI regulations about the issuance of a duplicate share certificate to the legal heir of a deceased shareholder. It includes details about folio numbers, certificate numbers, and shares, and mentions dispatch of a 'Letter of Confirmation' as per SEBI circular. The document is short (2021 characters) and is an announcement of a procedural compliance related to share certificates, not a financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. It is not a report itself but a regulatory compliance notification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-04-17 English
Shareholders meeting
Regulatory Filings
2023-03-23 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a notification to stock exchanges about the issuance of a duplicate share certificate due to loss of the original certificate by a shareholder. It references SEBI regulations and includes details of the shareholder and share certificate. There are no financial statements, earnings data, or management discussion. The document is an official regulatory announcement related to share certificates and shareholder records, not a financial report or meeting material. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-03-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.